GC Biopharma Corp. (006280.KS) KSC

127,800.00

-400(-0.31%)

Updated at October 20 09:14AM

Currency In KRW

Valuation

Market Cap2.05T
Enterprise Value2.85T
P/E Ratio19.87
PEG Ratio0.13
Price/Sales Ratio0.82
Price/Book Ratio1.14
Enterprise/Revenue1.4
Enterprise/EBITDA12.41

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.04
Operating Margin0.04

Management Effectiveness

Return On Assets0.02
Return On Equity0.06

Income Statement

Revenue1.68T
Revenue/Share156,820.46
Gross Profit481.93B
EBITDA80.36B
Net Income-26.28B
Diluted EPS-2,302.62

Balance Sheet

Total Cash85.61B
Total Cash/Share7,501.51
Total Debt1.12T
Total Debt/Equity0.88
Current Ratio1.19
Book Value Per Share128,611.73

Price History

52-Week Change-26.62
52-Week High181,800
52-Week Low111,800
Moving Average 50 Days132,478
Moving Average 200 Days132,764

Statistics

Average Volume35,220
Shares Outstanding11.41M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1,500
Trailing Annual Dividend Yield1.17
Payout Ratio0.29
Last Split Factor21:20
Last Split DateJune 07, 2013